Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson’s Disease and Atypical Parkinsonian Syndromes

BACKGROUND: We aimed to evaluate the utility of the combined use of cardiac (123)I-metaiodobenzylguanidine (MIBG) scintigraphy, olfactory testing, and substantia nigra (SN) hyperechogenicity on transcranial sonography (TCS) in differentiating Parkinson’s disease (PD) from atypical parkinsonian syndr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Fujita, Hiroaki, Suzuki, Keisuke, Numao, Ayaka, Watanabe, Yuji, Uchiyama, Tomoyuki, Miyamoto, Tomoyuki, Miyamoto, Masayuki, Hirata, Koichi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2016
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5094741/
https://ncbi.nlm.nih.gov/pubmed/27812167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0165869
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia